Severe COVID-19 is Associated With an Increased Subsequent Lung Cancer Risk: Study

New research shows that patients previously hospitalized with severe COVID-19 have an increased risk of lung cancer.

May 12, 2026

Hands holding a positive COVID test

In a new paper published in the journal Cell, researchers describe study results indicating that severe COVID-19 is associated with an increased subsequent lung cancer risk.

Their research found that people who were hospitalized with serious COVID-19 infections may have a higher risk of developing lung cancer. In animal studies, severe lung infections made existing lung cancers grow faster. However, COVID-19 vaccination helped reduce this effect.

The authors note that after a bad respiratory infection, lungs can remain inflamed for a while, making it easier for cancer to grow. The infection also seems to “reprogram” cells in the lungs, leaving behind long-term changes that can promote cancer.

However, the researchers also found that blocking certain immune signals helped restore the body’s ability to fight the cancer and slowed tumor growth.

Overall, the study suggests that severe viral lung infections like COVID-19 could increase cancer risk, and it highlights the importance of monitoring people after serious infections and developing treatments to reduce that risk.

At the Susan Wojcicki Foundation, we are working to better understand what puts someone at risk of developing lung cancer outside of traditional screening eligibility criteria.

Read the research paper.

Related Posts

Knowledge about this rare inherited gene change can empower those who may be at risk to speak to their doctor.
Foundation Updates and Press

Researchers identify a rare inherited gene mutation that substantially raises a person's risk of developing lung cancer

Knowledge about this rare inherited gene change can empower those who may be at risk to speak to their doctor.

Researchers identify a rare inherited gene mutation that substantially raises a person's risk of developing lung cancer
Foundation Updates and Press
Dr. Christine Berg, who led the trial that shaped today's lung cancer screening guidelines, argues it's time for policy to catch up with the science.
Foundation Updates and Press

Foundation Advisor Christine Berg Makes Case for Rethinking Lung Cancer Screening Policy

Dr. Christine Berg, who led the trial that shaped today's lung cancer screening guidelines, argues it's time for policy to catch up with the science.

Foundation Advisor Christine Berg Makes Case for Rethinking Lung Cancer Screening Policy
Foundation Updates and Press
Researchers found that a personal or family history of cancer was associated with a higher prevalence of lung cancer diagnosis after analyzing 12 years of health records for 2.8 million women.
Lung Cancer News

New research links family and personal cancer history to lung cancer risk

Researchers found that a personal or family history of cancer was associated with a higher prevalence of lung cancer diagnosis after analyzing 12 years of health records for 2.8 million women.

New research links family and personal cancer history to lung cancer risk
Lung Cancer News